IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2015. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $383,000 | -79.6% | 18,888 | -83.8% | 0.03% | -79.9% |
| Q2 2017 | $1,874,000 | -44.8% | 116,390 | -56.6% | 0.14% | -40.1% |
| Q1 2017 | $3,395,000 | +63.8% | 268,377 | +71.6% | 0.23% | +78.5% |
| Q4 2016 | $2,073,000 | -80.8% | 156,429 | -65.6% | 0.13% | -82.3% |
| Q3 2016 | $10,808,000 | -26.3% | 454,597 | -9.5% | 0.73% | -12.1% |
| Q2 2016 | $14,669,000 | -9.1% | 502,073 | -0.4% | 0.84% | -9.1% |
| Q1 2016 | $16,135,000 | -26.1% | 503,896 | -1.3% | 0.92% | -4.6% |
| Q4 2015 | $21,835,000 | +38.1% | 510,635 | +13.7% | 0.96% | +15.6% |
| Q3 2015 | $15,814,000 | -37.2% | 449,142 | -18.1% | 0.83% | -19.9% |
| Q2 2015 | $25,197,000 | -7.2% | 548,711 | -5.3% | 1.04% | -2.9% |
| Q1 2015 | $27,155,000 | +20.9% | 579,361 | -18.3% | 1.07% | +13.6% |
| Q4 2014 | $22,463,000 | +4.3% | 709,045 | -22.0% | 0.94% | +4.8% |
| Q3 2014 | $21,543,000 | -9.6% | 908,595 | +14.3% | 0.90% | -2.6% |
| Q2 2014 | $23,831,000 | +61.3% | 794,641 | +42.1% | 0.92% | +64.4% |
| Q1 2014 | $14,775,000 | +26.1% | 559,245 | +20.0% | 0.56% | +33.5% |
| Q4 2013 | $11,713,000 | – | 465,915 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 2,670,000 | $125,143,000 | 9.40% |
| Krensavage Asset Management, LLC | 410,944 | $19,261,000 | 8.77% |
| BANBURY PARTNERS LLC | 292,660 | $13,717,000 | 8.70% |
| Slate Path Capital LP | 1,935,000 | $90,693,000 | 5.72% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 285,000 | $13,358,000 | 4.69% |
| Orbimed Advisors | 6,678,000 | $312,998,000 | 2.67% |
| Pennant Capital Management, LLC | 2,025,000 | $94,912,000 | 1.78% |
| Iguana Healthcare Management, LLC | 75,000 | $3,515,000 | 1.48% |
| Leonard Capital Management, Inc. | 89,235 | $4,182,000 | 1.44% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $11,718,000 | 1.23% |